THE OPPORTUNITY
The END Fund is looking for a savvy, seasoned development professional to join its fundraising team, reporting to the VP, Investor Relations. They will develop and execute strategies to cultivate, solicit, and steward $100,000+ gifts from a portfolio of high-net-worth individuals, companies, and foundation partners and prospects, focused on the UK (and European) market. A natural and collegial team player, the successful candidate will have a demonstrated track record of working collaboratively in foundation, corporate and major gift fundraising with an eye towards executing on a robust plan.
ESSENTIAL FUNCTIONS & CORE COMPETENCIES
In concert with the Board of Directors, Board Development Committee, CEO, VP Investor Relations, and other colleagues, help execute a fundraising and marketing plan to secure funding towards the END Fund’s ambitious multi-year goals
Serve as one of the chief stewards of the END Fund brand by participating in cultivation meetings, correspondence, and events, and serving as the primary point of contact for Europe- and UK-based donors
Oversee the preparation of strategy, briefing and debriefing materials for face-to-face meetings with major donors conducted by senior staff or Board leadership
Lead and/or contribute to the research, preparation, drafting, and editing of major grant proposals
Design and execute ways to deepen donor commitment and enhanced gift giving, building on and enhancing the events and public outreach currently underway, while managing a personal portfolio of prospects
Oversee fundraising reporting by staff colleagues and consultants; liaise with program and other staff to gather materials and updates and translate them into proposals or donor reports, as needed
Perform other duties and responsibilities as assigned
EXPERIENCE AND EDUCATION
Bachelor’s degree preferred; relevant graduate coursework a plus
At least 8 years progressively responsible experience in nonprofit/charity fundraising and/or demonstrated transferable skills
Proven track record for cultivating, soliciting, and securing $100,000+ donations, and specific knowledge of private foundation and corporate grant making and high-net-worth cultivation strategies
Exceptional ability to convey complex ideas in a clear, direct, and lively style (both written and verbal)
Creative thinking to develop engagement strategies with maximum impact
Exceptional interpersonal and communication skills, especially writing and content creation
Confidence and poise to interact regularly with corporate executives and high-net-worth individuals using all forms of communications (e-mail, phone, videoconference and face-to-face interaction)
Familiarity with global health issues, and NTDs specifically, and/or an appetite and interest to learn
Demonstrated cross-cultural skills
A self-starter who enjoys working in a small team environment
Ability to work independently as well as a part of a collaborative team
Ability to work in the UK (or the European country in which the applicant proposes to work), and ability and desire to travel domestically and internationally
ORGANIZATIONAL OVERVIEW
The END Fund is the world’s leading collaborative philanthropic investment vehicle dedicated to controlling and eliminating neglected tropical diseases (NTDs). NTDs are parasitic and bacterial infectious diseases – including intestinal worms, river blindness, trachoma, schistosomiasis and lymphatic filariasis – that affect over 1.7 billion people globally. The END Fund’s vision is to ensure people can live healthy and prosperous lives free of the risk of NTDs and has set out to accomplish this by:
Mobilizing and investing resources for maximum impact,
Advocating for innovative, integrated and cost-effective NTD programs; and
Facilitating philanthropic and private sector engagement to end these diseases.
By engaging a community of activist-philanthropists and taking a systems approach, the END Fund works in collaboration with governments, local and international NGOs, pharmaceutical companies, and academic partners on the global campaign to control and eliminate the most prevalent NTDs by 2030.
Since our founding in 2012 through 2019, with our partners, the END Fund has provided over 920 million treatments for NTDs worth more than $1 billion. In 2019 alone, we reached more than 121 million people with more than 196 million NTD treatments, representing an almost 10-fold increase from 2012. The END Fund works globally in over 25 countries, with a primary emphasis in Africa.
You can read more about the END Fund and our 2019 impact story here.
ABOUT THE END FUND’S INVESTOR RELATIONS TEAM
The Investor Relations (fundraising) team is responsible for identifying, mobilizing, and nurturing meaningful and impactful partnerships to advance the END Fund’s mission to end neglected tropical diseases. Driven by the transformative power of collaborative philanthropy, the team works alongside a consortium of investors and champions to help harness and promote funding opportunities for underserved communities.
